SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cheryl S. Hankin, Linda Cox, Amy Bronstone, Zhaohui Wang, Allergy immunotherapy: Reduced health care costs in adults and children with allergic rhinitis, Journal of Allergy and Clinical Immunology, 2013, 131, 4, 1084

    CrossRef

  2. 2
    Anna Slovick, Abdel Douiri, Joanna Kelly, Andrea Guerra, Rachel Muir, Konstantinos Tsioulos, Caroline Murphy, Mohamed H Shamji, Sun Ying, Stephen R Durham, Stephen J Till, Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE), Clinical and Translational Allergy, 2013, 3, 1, 27

    CrossRef

  3. 3
    Philippe Moingeon, Adjuvants for allergy vaccines, Human Vaccines & Immunotherapeutics, 2012, 8, 10, 1492

    CrossRef

  4. 4
    Philippe Moingeon, Laurent Mascarell, Induction of Tolerance via the Sublingual Route: Mechanisms and Applications, Clinical and Developmental Immunology, 2012, 2012, 1

    CrossRef

  5. 5
    Philippe Moingeon, Vincent Lombardi, Nathalie Saint-Lu, Sophie Tourdot, Véronique Bodo, Laurent Mascarell, Adjuvants and Vector Systems for Allergy Vaccines, Immunology and Allergy Clinics of North America, 2011, 31, 2, 407

    CrossRef

  6. You have free access to this content6
    S. M. Walker, S. R. Durham, S. J. Till, G. Roberts, C. J. Corrigan, S. C. Leech, M. T. Krishna, R. K. Rajakulasingham, A. Williams, J. Chantrell, L. Dixon, A. J. Frew, S. M. Nasser, Immunotherapy for allergic rhinitis, Clinical & Experimental Allergy, 2011, 41, 9
  7. 7
    Aarif O. Eifan, Mohamed H. Shamji, Stephen R. Durham, Long-term clinical and immunological effects of allergen immunotherapy, Current Opinion in Allergy and Clinical Immunology, 2011, 11, 6, 586

    CrossRef

  8. 8
    G. Blumberga, L. Groes, R. Dahl, SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma, Allergy, 2011, 66, 2
  9. 9
    Moises A Calderon, Bernadette Alves, Mikila Jacobson, Brian Hurwitz, Aziz Sheikh, Stephen Durham, Cochrane review: Allergen injection immunotherapy for seasonal allergic rhinitis, Evidence-Based Child Health: A Cochrane Review Journal, 2010, 5, 3
  10. 10
    E. Maggi, T cell responses induced by allergen-specific immunotherapy, Clinical & Experimental Immunology, 2010, 161, 1
  11. 11
    Christine Loewenstein, Ralf S. Mueller, A review of allergen-specific immunotherapy in human and veterinary medicine, Veterinary Dermatology, 2009, 20, 2
  12. 12
    Alicja Kasperska-Zajac, Zenon Brzoza, Remission of chronic urticaria in the course of house dust mite immunotherapy—Mere coincidence or something more to it?, Vaccine, 2009, 27, 52, 7240

    CrossRef

  13. 13
    Linda Cox, James T. Li, Harold Nelson, Richard Lockey, Allergen immunotherapy: A practice parameter second update, Journal of Allergy and Clinical Immunology, 2007, 120, 3, S25

    CrossRef

  14. 14
    Giovanni Passalacqua, Stephen R. Durham, Allergic Rhinitis and its Impact on Asthma update: Allergen immunotherapy, Journal of Allergy and Clinical Immunology, 2007, 119, 4, 881

    CrossRef

  15. 15
    Linda Cox, Allergen immunotherapy: immunomodulatory treatment for allergic diseases, Expert Review of Clinical Immunology, 2006, 2, 4, 533

    CrossRef

  16. 16
    Eric Leith, Tom Bowen, Joe Butchey, David Fischer, Harold Kim, Bill Moote, Peter Small, Don Stark, Susan Waserman, Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI), Allergy, Asthma & Clinical Immunology, 2006, 2, 2, 47

    CrossRef

  17. 17
    A. Aslam, B. Kessler, M. Batycka, C. A. O'Callaghan, S. A. Misbah, D. A. Warrell, G. Ogg, Defining the T cell antigen proteome of wasp venom, Clinical & Experimental Allergy, 2006, 36, 10
  18. 18
    P. Moingeon, T. Batard, R. Fadel, F. Frati, J. Sieber, L. Overtvelt, Immune mechanisms of allergen-specific sublingual immunotherapy, Allergy, 2006, 61, 2
  19. 19
    Mark Larché, Cezmi A. Akdis, Rudolf Valenta, Immunological mechanisms of allergen-specific immunotherapy, Nature Reviews Immunology, 2006, 6, 10, 761

    CrossRef

  20. 20
    Laurent Mascarell, Laurence Van Overtvelt, Philippe Moingeon, Novel Ways for Immune Intervention in Immunotherapy: Mucosal Allergy Vaccines, Immunology and Allergy Clinics of North America, 2006, 26, 2, 283

    CrossRef

  21. 21
    Melanie Werner-Klein, Frank Kalkbrenner, Klaus J Erb, Sublingual immunotherapy of allergic diseases, Expert Opinion on Drug Delivery, 2006, 3, 5, 599

    CrossRef

  22. 22
    F. Puggioni, S. R. Durham, J. N. Francis, Monophosphoryl lipid A (MPL®) promotes allergen-induced immune deviation in favour of Th1 responses, Allergy, 2005, 60, 5
  23. 23
    James N Francis, Mark Larché, Peptide-based vaccination: where do we stand?, Current Opinion in Allergy and Clinical Immunology, 2005, 5, 6, 537

    CrossRef

  24. 24
    Andrew Liu, Harold Nelson, Childhood Asthma, 2005,

    CrossRef

  25. 25
    James N Francis, Stephen R Durham, Adjuvants for allergen immunotherapy: experimental results and clinical perspectives, Current Opinion in Allergy and Clinical Immunology, 2004, 4, 6, 543

    CrossRef

  26. 26
    S. T. H. P. Bolhaar, M. M. Tiemessen, L. Zuidmeer, A. Van Leeuwen, K. Hoffmann-Sommergruber, C. A. F. M. Bruijnzeel-Koomen, L. S. Taams, E. F. Knol, E. Van Hoffen, R. Van Ree, A. C. Knulst, Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges, Clinical & Experimental Allergy, 2004, 34, 5
  27. 27
    R. Valenta, T. Ball, M. Focke, B. Linhart, N. Mothes, V. Niederberger, S. Spitzauer, I. Swoboda, S. Vrtala, K. Westritschnig, D. Kraft, Advances in Immunology Volume 82, 2004,

    CrossRef

  28. 28
    Prem L Bhalla, Genetic engineering of pollen allergens for hayfever immunotherapy, Expert Review of Vaccines, 2003, 2, 1, 75

    CrossRef

  29. 29
    Robert Movérare, Immunological mechanisms of specific immunotherapy with pollen vaccines: implications for diagnostics and the development of improved vaccination strategies, Expert Review of Vaccines, 2003, 2, 1, 85

    CrossRef

  30. 30
    Hans-Jørgen Malling, Immunotherapy for rhinitis, Current Allergy and Asthma Reports, 2003, 3, 3, 204

    CrossRef

  31. 31
    Graham S. Ogg, T-cell immunotherapy of allergic disease: the role of CD8+ T cells, Current Opinion in Allergy and Clinical Immunology, 2003, 3, 6, 475

    CrossRef

  32. 32
    David B Lewis, Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy?, Current Opinion in Immunology, 2002, 14, 5, 644

    CrossRef

  33. 33
    WLG Oldfield, M Larché, AB Kay, Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial, The Lancet, 2002, 360, 9326, 47

    CrossRef

  34. 34
    Nina C Ramirez, Dennis K Ledford, Immunotherapy for allergic asthma, Medical Clinics of North America, 2002, 86, 5, 1091

    CrossRef

  35. 35
    Sylvia M Miescher, Monique Vogel, Molecular aspects of allergy, Molecular Aspects of Medicine, 2002, 23, 6, 413

    CrossRef

  36. 36
    A Kay, Mark Larché, Biotherapeutic Approaches to Asthma, 2002,

    CrossRef

  37. 37
    Hans-J??rgen Malling, Allergen-specific immunotherapy in allergic rhinitis, Current Opinion in Allergy and Clinical Immunology, 2001, 1, 1, 43

    CrossRef

  38. 38
    Ian R. Mackay, Fred S. Rosen, A.B. Kay, Allergy and Allergic Diseases, New England Journal of Medicine, 2001, 344, 2, 109

    CrossRef

  39. 39
    D. R. Wilson, A.-MA. Irani, S. M. Walker, M. R. Jacobson, I. S. Mackay, L. B. Schwartz, S. R. Durham, Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium, Clinical & Experimental Allergy, 2001, 31, 11
  40. 40
    Duncan R. Wilson, Kayhan T. Nouri-Aria, Samantha M. Walker, Giovanni B. Pajno, Fiona O’Brien, Mikila R. Jacobson, Ian S. Mackay, Stephen R. Durham, Grass pollen immunotherapy: Symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season, Journal of Allergy and Clinical Immunology, 2001, 107, 6, 971

    CrossRef

  41. 41
    S. Dreborg, Histamine reactivity of the skin, Allergy, 2001, 56, 5
  42. 42
    F. Leynadier, L. Banoun, B. Dollois, P. Terrier, M. Epstein, M.-T. Guinnepain, D. Firon, C. Traube, R. Fadel, C. André, Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study, Clinical & Experimental Allergy, 2001, 31, 7
  43. 43
    G. Pauli, A. Purohit, Méthodologie d'un essai clinique de désensibilisation, Revue Française d'Allergologie et d'Immunologie Clinique, 2001, 41, 1, 55

    CrossRef

  44. 44
    Sten K.G. Dreborg, Skin Testing in Allergen Standardization and Research, Immunology and Allergy Clinics of North America, 2001, 21, 2, 329

    CrossRef

  45. 45
    Dennis K. Ledford, EFFICACY OF IMMUNOTHERAPY, Immunology and Allergy Clinics of North America, 2000, 20, 3, 503

    CrossRef

  46. 46
    Elizabeth C. TePas, Dale T. Umetsu, Immunotherapy of asthma and allergic diseases, Current Opinion in Pediatrics, 2000, 12, 6, 574

    CrossRef

  47. 47
    Bradding, Allergen immunotherapy and mast cells, Clinical & Experimental Allergy, 1999, 29, 11
  48. 48
    Moises A Calderon, Bernadette Alves, Mikila Jacobson, Brian Hurwitz, Aziz Sheikh, Stephen Durham, Allergen injection immunotherapy for seasonal allergic rhinitis, The Cochrane Library,